|
1
|
Kuna AT: Serological markers of
inflammatory bowel disease. Biochem Med (Zagreb). 23:28–42. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamamoto-Furusho JK: Clinical epidemiology
of ulcerative colitis in Mexico: A single hospital-based study in a
20-year period (1987–2006). J Clin Gastroenterol. 43:221–224. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cronica, . In Mexico there was a triple
increase in the number of cases of inflammatory bowel disease.
http://www.cronica.com.mx/notas/2017/1015339.html(In
Spanish). July 21–2017
|
|
4
|
Cosnes J, Gower-Rousseau C, Seksik P and
Cortot A: Epidemiology and natural history of inflammatory bowel
diseases. Gastroenterology. 140:1785–1794. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Solberg IC, Lygren I, Jahnsen J, Aadland
E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH,
et al: Clinical course during the first 10 years of ulcerative
colitis: Results from a population-based inception cohort (IBSEN
Study). Scand J Gastroenterol. 44:431–440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sandborn WJ, Feagan BG, Hanauer SB, Lochs
H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J,
Stange EF and Sutherland LR: A review of activity indices and
efficacy endpoints for clinical trials of medical therapy in adults
with Crohn's disease. Gastroenterology. 122:512–530. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stange EF, Travis SP, Vermeire S,
Beglinger C, Kupcinkas L, Geboes K, Barakauskiene A, Villanacci V,
Von Herbay A, Warren BF, et al: European evidence based consensus
on the diagnosis and management of Crohn's disease: Definitions and
diagnosis. Gut. 1 55 Suppl:11–15. 2006.
|
|
8
|
Van Assche G, Dignass A, Panes J,
Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T,
Rogler G, Louis E, et al: The second European evidence-based
consensus on the diagnosis and management of Crohn's disease:
Definitions and diagnosis. J Crohns Colitis. 4:7–27. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Colombel JF, Sandborn WJ, Reinisch W,
Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G,
Diamond RH, Broussard DL, et al: Infliximab, azathioprine, or
combination therapy for Crohn's disease. N Engl J Med.
362:1383–1395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Beaugerie L, Brousse N, Bouvier AM,
Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y,
Gendre JP, et al: Lymphoproliferative disorders in patients
receiving thiopurines for inflammatory bowel disease: A prospective
observational cohort study. Lancet. 374:1617–1625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peyrin-Biroulet L, Khosrotehrani K, Carrat
F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas
JL, Godeberge P, et al: Increased risk for nonmelanoma skin cancers
in patients who receive thiopurines for inflammatory bowel disease.
Gastroenterology. 141:1621–1628.e1-5. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beaugerie L and Sokol H: Clinical,
serological and genetic predictors of inflammatory bowel disease
course. World J Gastroenterol. 18:3806–3813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ehsani AH, Mortazavi H, Balighi K,
Hosseini MS, Azizpour A, Hejazi SP, Goodarzi A and Darvari SB:
Changes in body mass index and lipid profile in psoriatic patients
after treatment with standard protocol of infliximab. Acta Med
Iran. 54:570–575. 2016.PubMed/NCBI
|
|
14
|
Kopp A, Buechler C, Neumeier M, Weigert J,
Aslanidis C, Schölmerich J and Schäffler A: Innate immunity and
adipocyte function: Ligand-specific activation of multiple
Toll-like receptors modulates cytokine, adipokine, and chemokine
secretion in adipocytes. Obesity (Silver Spring). 17:648–656. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schäffler A, Schölmerich J and Salzberger
B: Adipose tissue as an immunological organ: Toll-like receptors,
C1q/TNFs and CTRPs. Trends Immunol. 28:393–399. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schäffler A and Buechler C: CTRP family:
Linking immunity to metabolism. Trends Endocrinol Metab.
23:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Friedman JM and Halaas JL: Leptin and the
regulation of body weight in mammals. Nature. 395:763–770. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lennard-Jones JE: Classification of
inflammatory bowel disease. Scand J Gastroenterol Suppl. 170:2–6;
discussion 16–19. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bruun JM, Pedersen SB, Kristensen K and
Richelsen B: Effects of pro-inflammatory cytokines and chemokines
on leptin production in human adipose tissue in vitro. Mol Cell
Endocrinol. 190:91–99. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirchgessner TG, Uysal KT, Wiesbrock SM,
Marino MW and Hotamisligil GS: Tumor necrosis factor-alpha
contributes to obesity-related hyperleptinemia by regulating leptin
release from adipocytes. J Clin Invest. 100:2777–2782. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Waluga M, Hartleb M, Boryczka G, Kukla M
and Zwirska-Korczala K: Serum adipokines in inflammatory bowel
disease. World J Gastroenterol. 20:6912–6917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bernstein CN, Eliakim A, Fedail S, Fried
M, Gearry R, Goh KL, Hamid S, Khan AG, Khalif I, Ng SC, et al:
World gastroenterology organisation global guidelines inflammatory
bowel disease: Update August 2015. J Clin Gastroenterol.
50:803–818. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Winawer SJ, Krabshuis J, Lambert R,
O'Brien M and Fried M; World Gastroenterology Organization
Guidelines Committee, : Cascade colorectal cancer screening
guidelines: A global conceptual model. J Clin Gastroenterol.
45:297–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
American Society for Gastrointestinal
Endoscopy Standards of Practice Committee, ; Shergill AK, Lightdale
JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi KV, Decker
GA, Early DS, Evans JA, et al: The role of endoscopy in
inflammatory bowel disease. Gastrointest Endosc.
81:1101–1121.e1-13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Travis SP, Schnell D, Krzeski P, Abreu MT,
Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lémann M,
Lichtenstein GR, et al: Developing an instrument to assess the
endoscopic severity of ulcerative colitis: The Ulcerative colitis
endoscopic index of severity (UCEIS). Gut. 61:535–542. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
D'Haens G, Sandborn WJ, Feagan BG, Geboes
K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P,
Schölmerich J and Sutherland LR: A review of activity indices and
efficacy end points for clinical trials of medical therapy in
adults with ulcerative colitis. Gastroenterology. 132:763–786.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barnes EL and Burakoff R: New biomarkers
for diagnosing inflammatory bowel disease and assessing treatment
outcomes. Inflamm Bowel Dis. 22:2956–2965. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang P, Mariman E, Renes J and Keijer J:
The secretory function of adipocytes in the physiology of white
adipose tissue. J Cell Physiol. 216:3–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bastard JP, Maachi M, Lagathu C, Kim MJ,
Caron M, Vidal H, Capeau J and Feve B: Recent advances in the
relationship between obesity, inflammation, and insulin resistance.
Eur Cytokine Netw. 17:4–12. 2006.PubMed/NCBI
|
|
30
|
Sobhani I, Bado A, Vissuzaine C, Buyse M,
Kermorgant S, Laigneau JP, Attoub S, Lehy T, Henin D, Mignon M and
Lewin MJ: Leptin secretion and leptin receptor in the human
stomach. Gut. 47:178–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karmiris K, Koutroubakis IE, Xidakis C,
Polychronaki M, Voudouri T and Kouroumalis EA: Circulating levels
of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel
disease. Inflamm Bowel Dis. 12:100–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tuzun A, Uygun A, Yesilova Z, Ozel AM,
Erdil A, Yaman H, Bagci S, Gulsen M, Karaeren N and Dagalp K:
Leptin levels in the acute stage of ulcerative colitis. J
Gastroenterol Hepatol. 19:429–432. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ballinger A, Kelly P, Hallyburton E,
Besser R and Farthing M: Plasma leptin in chronic inflammatory
bowel disease and HIV: Implications for the pathogenesis of
anorexia and weight loss. Clin Sci (Lond). 94:479–483. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoppin AG, Kaplan LM, Zurakowski D,
Leichtner AM and Bousvaros A: Serum leptin in children and young
adults with inflammatory bowel disease. J Pediatr Gastroenterol
Nutr. 26:500–505. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barbier M, Vidal H, Desreumaux P, Dubuquoy
L, Bourreille A, Colombel JF, Cherbut C and Galmiche JP:
Overexpression of leptin mRNA in mesenteric adipose tissue in
inflammatory bowel diseases. Gastroenterol Clin Biol. 27:987–991.
2003.PubMed/NCBI
|
|
36
|
Paul G, Schäffler A, Neumeier M, Fürst A,
Bataillle F, Buechler C, Müller-Ladner U, Schölmerich J, Rogler G
and Herfarth H: Profiling adipocytokine secretion from creeping fat
in Crohn's disease. Inflamm Bowel Dis. 12:471–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Franchimont D, Roland S, Gustot T,
Quertinmont E, Toubouti Y, Gervy MC, Deviere J and Van Gossum A:
Impact of infliximab on serum leptin levels in patients with
Crohn's disease. J Clin Endocrinol Metab. 90:3510–3516. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bennett BD, Solar GP, Yuan JQ, Mathias J,
Thomas GR and Matthews W: A role for leptin and its cognate
receptor in hematopoiesis. Curr Biol. 6:1170–1180. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Togo M, Tsukamoto K, Satoh H, Hara M,
Futamura A, Nakarai H, Nakahara K and Hashimoto Y: Relationship
between levels of leptin and hemoglobin in Japanese men. Blood.
93:4444–4445. 1999.PubMed/NCBI
|
